[Congressional Record Volume 171, Number 60 (Thursday, April 3, 2025)]
[Senate]
[Page S2226]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1546. Ms. WARREN (for herself and Mr. Markey) submitted an 
amendment intended to be proposed by her to the concurrent resolution 
H. Con. Res. 14, establishing the congressional budget for the United 
States Government for fiscal year 2025 and setting forth the 
appropriate budgetary levels for fiscal years 2026 through 2034; which 
was ordered to lie on the table; as follows:

       At the appropriate place, insert the following:

     SEC. ___. POINT OF ORDER AGAINST CONSIDERATION OF ANY 
                   LEGISLATION UNTIL THE CAP ON NIH FUNDING FOR 
                   RESEARCH AND CLINICAL TRIALS ON RARE DISEASES, 
                   CHRONIC DISEASES, PEDIATRIC DISEASES, CANCER, 
                   ALZHEIMER'S DISEASE, DIABETES, AND CYSTIC 
                   FIBROSIS IS LIFTED.

       (a) Point of Order.--It shall not be in order in the Senate 
     to consider any bill, joint resolution, motion, amendment, 
     amendment between the Houses, or conference report until the 
     date on which the 15 percent cap on the use of National 
     Institutes of Health funding for indirect costs is lifted for 
     institutions that conduct research or clinical trials on rare 
     diseases, chronic diseases, pediatric diseases, cancer, 
     Alzheimer's disease, diabetes, or cystic fibrosis.
       (b) Waiver and Appeal.--Subsection (a) may be waived or 
     suspended in the Senate only by an affirmative vote of three-
     fifths of the Members, duly chosen and sworn. An affirmative 
     vote of three-fifths of the Members of the Senate, duly 
     chosen and sworn, shall be required to sustain an appeal of 
     the ruling of the Chair on a point of order raised under 
     subsection (a).
                                 ______